G72.2

Clinical Causes: Prolonged exposure to certain medications, such as corticosteroids or statins Ingestion or inhalation of industrial chemicals, solvents, or toxins Use of recreational drugs that have myotoxic effects Environmental exposure to heavy metals like lead or mercury Chronic alcohol consumption Poisoning from drugs or chemicals that interfere with muscle cell function

Key Symptoms: Progressive muscle weakness, especially in the proximal muscles (hips and shoulders) Muscle cramps or stiffness Muscle pain or tenderness Fatigue during physical activity Difficulty performing tasks that require muscle strength, such as climbing stairs or lifting objects Potentially, muscle wasting or atrophy with prolonged exposure

Diagnosis Path: Diagnosing myopathy caused by toxic agents involves a combination of medical history, physical examination, and laboratory tests. Healthcare providers may order blood tests to check for elevated muscle enzymes like creatine kinase (CK), which often indicates muscle damage. Electromyography (EMG) and muscle biopsy could be used to assess muscle function and tissue health. Additionally, identifying relevant exposure history to potential toxins is crucial. Imaging studies can sometimes help to evaluate muscle and nerve integrity.

Treatment Protocols: Treatment primarily focuses on removing or reducing exposure to the toxic agent responsible for the myopathy. Supportive care may include physical therapy to help recover muscle strength and function. In some cases, medications or interventions to manage symptoms could be recommended. Monitoring and addressing any underlying health issues, such as liver or kidney problems related to toxin exposure, are also essential. Close follow-up with healthcare providers is important to track recovery and prevent further damage.